← Back to Search

Resonance breathing for Excessive Alcohol Consumption

N/A

Recruiting

Led By Brandon L Alderman, Ph.D.

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediate; difference between the active resonance breathing compared to the low demand cognitive task occurring one week apart

Awards & highlights

Study Summary

This trial will study whether slow breathing can help people with a history of binge drinking better control their impulse to drink when they see alcohol cues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediate; difference between the active resonance breathing compared to the low demand cognitive task occurring one week apart

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediate; difference between the active resonance breathing compared to the low demand cognitive task occurring one week apart

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate; difference between the active resonance breathing compared to the low demand cognitive task occurring one week apart for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

N2 ERP amplitude (in microvolts) elicited from an Alcohol Cued Go/No-Go task

N2 ERP latency (in milliseconds) elicited from an Alcohol Cued Go/No-Go task

N2pc ERP amplitude (in microvolts) elicited from a visual dot probe detection task

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Resonance paced breathingExperimental Treatment1 Intervention

Active resonance breathing task consisting of synchronizing breathing with a visual pacer (E-Z Air, Thought Technology, Ltd., Plattsburgh, NY) that moves up (inhale) and down (exhale) at the rate of 0.1 Hz (6 breaths per min)

Group II: Low demand vanilla controlActive Control1 Intervention

A low-demand cognitive "vanilla" task wherein different colored rectangles are presented for 10 sec each, and participants are instructed to silently count the number of blue rectangles

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,132 Total Patients Enrolled

Brandon L Alderman, Ph.D.Principal InvestigatorRutgers, The State University of New Jersey

Marsha E Bates, Ph.D.Principal InvestigatorRutgers, The State University of New Jersey

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being accepted into this research endeavor?

"Affirmative. Clinicaltrials.gov's information indicates that this research project, which was initially published on July 1st 2022, is actively seeking volunteers. The trial requires 100 individuals to be recruited from a single clinical site."

Answered by AI

Could individuals of advanced age potentially partake in this medical trial?

"Those who are between 18 and 35 years old meet the requirements for this investigation. There also exist two trials geared towards those under 18 and three studies targeting individuals above 65."

Answered by AI

What types of individuals qualify for this medical research program?

"This research seeks 100 individuals between 18 and 35 years old that engage in binge drinking. To be considered, applicants must report engaging in at least two episodes within the last month, as well as having normal or corrected-to-normal vision."

Answered by AI

Are there still open opportunities to join this experiment?

"As seen on clinicaltrials.gov, this clinical trial is presently recruiting patients. It was initially published on July 1st 2022 and recently revised on the fifteenth of that same month."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control

Brandon Alderman, Ph.D. 2022. "Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05369169.